Klarna offer smoooth payments to 130.000 webshops and retailers across the globe. The company has 2500 employees spread over our 14 markets. Klarna Checkout is the main product, which offers merchants 1 integration, 1 agreement, 1 settlement for handling payments online and in stores. Klarna Norway AS has 15 (and increasing) employees who work at the 26th floor at Posthuset in Oslo.

Amina Charging is a technology startup on a mission to give our planet a greener future by scaling the transition to electric vehicles (EV). We create environmental sustainability solutions grounded in sound business and global scalability. We work and play with curiosity, creativity and ambition. At Amina, we never compromise on sustainability, scale and sound business. We work with passion and insight, and prize impact and progress over process. We empower your creative autonomy but you will never struggle alone. We work as a team in an open culture that rewards sharing ideas and supporting each other.

RESPINOR is a privately-owned medical device company, founded in Oslo, 2015. We have developed an objective measure of breathing for critically ill patients within intensive care. The technology provides precise, continuous and real-time information of diaphragm function, our main breathing muscle, to increase the quality of care and reducing costs. RESPINOR’s technology is the winner of Horizon 2020 both in phase I and II. We are addressing an unmet medical need because every breath counts.

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

Think Outside is now Mitta AS, a subsidiary fully owned by Mitta Oy. Mitta will be offering geodata monitoring and measurement services to the Norwegian market, bridging the growth of the Finnish and Swedish Mitta companies to new Norwegian customers. For us at Mitta, accurate and reliable positioning is extremely important, as it is a basic prerequisite for spatial information. High-quality input data means cost-effectiveness in design, construction and monitoring, regardless of the customer's industry. Mitta is the market leader as a producer and processor of terrain information in the infrastructure sector in Finland and Sweden. Our customers operate in the construction value chain from design to production.

Fishency Innovation can give access to the entire salmon industry to affordable equipment to count automatically sea lice in the cage. Monitoring sea lice is the key to controlling them, it is access to good decision support for optimized treatments and to a reliable tool to measure the efficiency of preventive measures and existing treatments. Today, sea lice are counted manually over 20 fish, every week, in each cage. It is labor-demanding, and the collected data are not reliable. Sustainability starts with good data.

Based in Kongsberg - the heart of the Subsea Valley - Kongsberg Ferrotech is utilizing world-leading competence to develop the first-ever automated solution, the Oktapous, for riser cleaning, NDT inspection, maintenance (coating), and structural repair (glass/carbon fiber reinforcement). The repair will be performed inside the patented Habitat - allowing for composite repairs subsea and in the splash zone while offering quality as if the repair was performed in a laboratory environment. The Oktapous will offer the client around 50% cost reduction, together with improved quality and significantly reduced HSE risk compare to existing solutions by removing the need for rope access, divers, and ROVs. Kongsberg Ferrotech is partly funded by the Malaysian-based oil and gas company, Petronas Charigali. This ensures us access to the market needs during development, an offshore platform for prototype testing, and the critical first client for market acceptance. Schedule highlights: • Development started in September 2015 • Stack-up/dry test in December 2017 • TRL4 testing submerged in February 2018 • Offshore testing on Petronas assets in Q3 2018 • Commercial operations in Q2-3 2019

Vimond provides online streaming software and services for broadcasters and content providers worldwide. Our local team counts 62 people from 17 nations, of which a majority are developers with a strong passion and expertise in online video workflows and innovative software and web development. As we continue to grow our team, we are always looking for people with relevant experience in media technology, software development, product development, system administration & dev ops, tech team lead roles, project management, account management, and solution architect roles. Contact us for an informal chat!

Goscore - a fair human credit scoring company. We help banks to increase creditworthy customers by as much as 19% while reducing default rates by as much as 49%. Banks can not only see «can» consumers repay a loan, but «will» they do that. Unlike other credit reference agencies, who rely on outdated tax reports, we leverage up-to-date transactional data to build a real-time comprehensive financial profile. Like many Europeans, we have experienced that traditional credit scoring is unfair and does not consider you creditworthy, even if: - you are a successful entrepreneur, - a blogger with a million subscribers, - decide to get your first credit card, or - you moved from one country to another. So, goscore brings a new golden standard of fair human credit scoring for the EU.

Bad Forecasts Kill Businesses: Working capital cost, natural resource waste, overproduction, lost sales... MIR is the Sherlock Holmes for your business. We identify the most important influence factors out of billions of market data for maximum profit, minimum waste, thanks to the best forecasting accuracy.

Spect8 is a norwegian tech startup with a mission to help sports organizations, pro-athletes and sponsors that don’t have enough time, capacity, or the necessary skills to reach their potential in growing fan engagement and commercial value. Due to the power of association among consumers, brands allocate an increasing amount of their advertising budgets towards sports teams and athletes. To measure the value of a sponsorship, sponsors rely on manual measurements and expensive consulting services. At the same time, athletes, clubs, and federations are left with few resources to decide what their commercial value is, and often forfeit revenue (and funding for their sport) by underselling their commercial value. To solve this problem, we have developed a tool called Foqus. Foqus is an easy-to-use machine learning tool created for sports teams and individual athletes to determine their commercial value for sponsorships, and for brands to manage and measure multiple agreements. We are currently working with Norsk Toppfotball, sports associations, clubs and and several brands, and are off to a good start to reach our goal of creating a new industry standard for how sponsorship value is created, measured, and driven. The existing team consists of three business developers with expertise in strategy, marketing, sponsorship, data and analysis. In addition, we have associated development teams with both front-end, back-end and database expertise. We have recently become a part of StartupLab's Accelerator program, are supported by Innovation Norway and have ambitions to scale our business both nationally and internationally in the coming years. We therefore wish to expand our team with a skilled developer who also wants to make a professional career as an entrepreneur. The CTO will have the overall responsibility for the further development and scaling of our core product, Foqus, as well as the development of new tools and concepts going forward.

DoMore Diagnostics is on a mission to transform cancer diagnostics with artificial intelligence to improve patient care and make drug development more effective. We use state-of-the-art methods to improve patients’ quality of life and help clinicians make more informed decisions. Our technology is based on pioneering research on utilizing artificial intelligence to increase the prognostic value from routine clinical pathology cancer tissue samples. The extensive research conducted at top universities (University in Oslo, Oxford University and University College of London) has been published in leading and high impact scientific journals such as The Lancet and Nature Reviews Cancer. These new methods have resulted in fully automated histotyping that provide objective and precise prognostic information that correlate and out-perform existing markers. This novel histotyping can guide selection of therapy to avoid over- and undertreatment. It can also make cancer drug development more effective by ensuring more precise diagnosis and prognosis, which is the fundament for precision medicine. Artificial intelligence is set for a breakthrough in medicine and several megatrends are pushing for new solutions in cancer diagnostics. Digital pathology and new AI algorithms will play a significant role in the future of medicine and hold multiple commercial opportunities. DoMore Diagnostics is at the forefront of the field and will bring these next generation products to the clinic.

CURRENT was founded with a vision to make owning and managing EV chargers easy and accessible. Since 2013, we have been working to solve the challenges related to charging infrastructure by bringing together the tools and expertise needed to manage and operate charging points in one place. Today, we have helped over 150,000 users with more than 20,000 charging points across seven different countries.

Norway’s unique landscape necessitates one of the most extensive tunnel networks in the world. 1800 road and rail tunnels contribute to 9000km of tunnel in Norway. These are inspected manually by eye and on foot, a time-consuming and hazardous process producing only qualitative data on tunnel safety. To combat these issues, Techrail aims to provide an integrated solution that is safer for inspectors, that does not interfere with traffic, and more comprehensively evaluates the safety of tunnels. Our solution enables the measuring the change of a tunnel’s surface over time, which allows tunnel directors to predict maintenance needs and more accurately evaluate the state of their tunnels. A digital paper trail will also aid regulators in overseeing tunnel maintenance. Furthermore, our technology has a large number of secondary uses that provide value such as Building Information Modeling (BIM), tunnel construction, and crack detection.

We make Dreams come true, so can you. 💫 Call us dreamers if you like, but we want to help people feel good about money. In a world of overspending and easy credit, it’s no surprise that money is the number one source of stress for millions of people. We created Dreams to level the playing field. To give people a better chance of achieving their goals, and a simple way to take control of their finances. We use behavioral science to design financial services that fit neatly into people’s lives, making it easier to save, invest and pay off debt. As a result, the Dreams app is personal, easy to use and incredibly effective. It’ll even help you find money you didn’t know you had.